EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study

Michael Weichenthal, Eva Ellebaek, Joanna Mangana, Nethanel Asher, Iva Gavrilova, Lidija Kandolf, Selma Ugurel, Axel Hausschild, Friedegund Meier, Ulrike Leiter, Elisabeth Livingstone, Christoffer Gebhardt und 37 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Michael Weichenthal und 48 weiteren Autor:innen. Beteiligte Einrichtung: Skin Cancer Center Kiel, University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: MWeichenthal@dermatology.uni-kiel.de. Hauptthemen laut MEDLINE: Melanoma, Immune Checkpoint Inhibitors, Skin Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaImmune Checkpoint InhibitorsSkin NeoplasmsProgrammed Cell Death 1 ReceptorHumansFemaleMaleMiddle AgedAgedAdultChemotherapy, AdjuvantRegistriesAged, 80 and overTreatment Failure

Stichwörter der Autor:innen

Adjuvant treatmentImmunotherapyMelanomaResistance

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • Skin Cancer Center Kiel, University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: MWeichenthal@dermatology.uni-kiel.de.
  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Skin Cancer and Melanoma Center at Davidoff Cancer Center, Rabin Medical Center, Israel.
  • Oncodermatology Department, National Oncology Center, Sofia, Bulgaria.
  • Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.

Zitieren

APA

Weichenthal, M., Ellebaek, E., Mangana, J., Asher, N., Gavrilova, I., Kandolf, L., Ugurel, S., Hausschild, A., Meier, F., Leiter, U., Livingstone, E., Gebhardt, C., Gutzmer, R., Ruhlmann, C. H., Mahncke-Guldbrandt, L., Haslund, C. A., Kopec, S., Teterycz, P., Bender, M., …, & EUMelaReg Consortium Members (2025). Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115339

Vancouver

Weichenthal M, Ellebaek E, Mangana J, Asher N, Gavrilova I, Kandolf L, et al. Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115339

BibTeX
@article{Weichenthal2025,
  author = {Weichenthal, Michael and Ellebaek, Eva and Mangana, Joanna and Asher, Nethanel and Gavrilova, Iva and Kandolf, Lidija and Ugurel, Selma and Hausschild, Axel and Meier, Friedegund and Leiter, Ulrike and Livingstone, Elisabeth and Gebhardt, Christoffer and Gutzmer, Ralf and Ruhlmann, Christina H and Mahncke-Guldbrandt, Louise and Haslund, Charlotte A and Kopec, Sylwia and Teterycz, Paweł and Bender, Marc and Poudroux, Wilfried and Muñoz-Couselo, Eva and Berciano-Guerrero, Miguel-Angel and Shalamanova, Gergana and DePalo, Danielle K and Brozić, Jasmina Marić and Chiarion-Sileni, Vanna and Arance, Anna and Ziogas, Dimitrios and Robert, Caroline and van de Velde, Anthonie Obik and Gassama, Awa Aminata and Shapira, Ronnie and BenBetzalel, Guy and Grynberg, Shirly and Ramelyte, Egle and Bertoldo, Fabio and DelPrete, Valerio and Gaudy-Marqueste, Caroline and Mohr, Peter and Dummer, Reinhard and Ascierto, Paolo A and Gogas, Helen and Espinosa, Enrique and Lebbé, Celeste and Rutkowski, Piotr and Haanen, John and Schadendorf, Dirk and Svane, Inge Marie and EUMelaReg Consortium Members, EUMelaReg Consortium Members},
  title = {Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115339}
}
Kostenlos starten →